{"organizations": [], "uuid": "31c13b3e3c7526f03871bcf70c7485d9454cb0c3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180328.html", "section_title": "Archive News &amp; Video for Wednesday, 28 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/ip-patent-mohawk/federal-circuit-halts-ptab-review-of-allergan-patents-owned-by-tribe-idUSL1N1RB02S", "country": "US", "domain_rank": 408, "title": "Federal Circuit halts PTAB review of Allergan patents owned by tribe", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-29T09:27:00.000+03:00", "replies_count": 0, "uuid": "31c13b3e3c7526f03871bcf70c7485d9454cb0c3"}, "author": "Jan Wolfe", "url": "https://www.reuters.com/article/ip-patent-mohawk/federal-circuit-halts-ptab-review-of-allergan-patents-owned-by-tribe-idUSL1N1RB02S", "ord_in_thread": 0, "title": "Federal Circuit halts PTAB review of Allergan patents owned by tribe", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "ptab", "sentiment": "negative"}, {"name": "allergan", "sentiment": "negative"}, {"name": "federal circuit", "sentiment": "negative"}, {"name": "allergan plc", "sentiment": "none"}, {"name": "westlaw", "sentiment": "none"}, {"name": "patent trial and appeal board", "sentiment": "none"}, {"name": "u.s. court of appeals", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 29, 2018 / 1:27 AM / Updated 18 hours ago Federal Circuit halts PTAB review of Allergan patents owned by tribe Jan Wolfe 1 Min Read \nA U.S. appeals court on Wednesday instructed a U.S. patent tribunal to hold off on deciding the validity of patents covering Allergan PLCâ€™s drug Restasis, saying it first wanted to consider the novel jurisdictional issues raised by Allergan assigning the patents to a Native American tribe. \nThe U.S. Court of Appeals for the Federal Circuit granted a request by the Saint Regis Mohawk Tribe for a temporary stay that blocks the Patent Trial and Appeal Board from ruling on the validity of the patents on Restasis, a dry eye treatment that generates more than $1 billion a year in revenue. \nTo read the full story on Westlaw Practitioner Insights, click here: bit.ly/2pLNrfu", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "http://bit.ly/2pLNrfu", "https://instagram.com/reuters/"], "published": "2018-03-29T09:27:00.000+03:00", "crawled": "2018-03-29T16:10:50.011+03:00", "highlightTitle": ""}